500 patients67,039 observations150 daysLIVE

Patient P-03449

Synthetic patientONX-7 · Day 148 · 75+ · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
41%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S14
  2. Day 68 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 69 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 70 Patient acceptedStarted DT-01 in the companion
  5. Day 75 GI symptom burden −16% vs expectedDosing / Timing Recommendation DT-01
  6. Day 81 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 68.

Primary contributors, last 14 days
  • GI instability+11
  • Nutritional resilience+8
  • Treatment adherence-5
  • Toxicity+5
  • Inflammatory activity+4

What helped?

  • Dosing / Timing Recommendation DT-01Day 69
    Result: symptom burden −16%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
5.1/10
worsening · -0.5 vs previous 14 d
Stress level
Daily log
3.8/10
worsening · +0.3 vs previous 14 d
Pessimism score
Daily log
3/10
stable · +0.0 vs previous 14 d
Sleep quality
Wearable
39.4/100
worsening · -3.6 vs previous 14 d
Libido
Daily log
4.8/10
worsening · -0.4 vs previous 14 d
HRV
Wearable
72.3 ms
stable · -0.6 vs previous 14 d
Toxicity
Blood
20/100
worsening · +7.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 79 from the failing basin, 11 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.7 next day on high-intake days · n 20
Would not help
  • HY-01 Hydration Protocol
    only 44% improved among 9 similar
  • Keep histamine low
    GI +4.2 next day on high-intake days · n 14
  • Keep alcohol low
    GI +4 next day on high-intake days · n 15
  • Keep caffeine low
    GI +3.8 next day on high-intake days · n 18
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -5.7supporter · 95%
  • Histamine load
    +4.2detractor · 95%
  • Alcohol
    +4detractor · 95%
  • Caffeine
    +3.8detractor · 95%
  • Lactose
    +3.5detractor · 86%
  • Dietary fat load
    -1.7no signal · 34%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Autonomic recovery 65
    • WearableResting HR 75 bpm
    • Wearable3,878 steps/day
    • WearableShort sleep window
  • Mucosal barrier integrity 40
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • WearableSleep 6.1 h, below personal baseline
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
Microbiome
Shannon diversity 3.2 · butyrate capacity 61/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
68 ms
Sleep
6.3 h
Steps
5,229
Resting HR
72 bpm
Daily log: GI score 27, nutritional resilience 64, adherence 94.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0315229%S1798
P-0312633%S0197
P-0314134%S0295
P-0300231%S2093
P-0343929%S0692
P-0335833%S1592
P-0304828%S1991
P-0333331%S14SC-12improved91
P-0301729%S0690
P-0301037%S0390
P-0334231%S1189
P-0339335%S1489